info@australiarxmeds.com
🔍 Shop Now menu
×
Request a Callback
☎ +1 256 6644170
✉ info@australiarxmeds.com

Type 2 Diabetes: Causes, Symptoms, Diagnosis, Treatment and Long-Term Complications

By Dr. Arjun Srivastav, Nov-20-2026  

Type 2 Diabetes
Written By-Dr. Arjun Srivastav  Medical Reviewer (Pharm D)
 • Published: 11/20/2026
• Updated: 11/20/2026

Listen to this article
Ready
0:00

Type 2 diabetes is one of the most prevalent chronic metabolic conditions worldwide, affecting hundreds of millions of adults and placing a substantial health burden on communities across Australia and globally. Characterised by persistently elevated blood glucose (hyperglycaemia), Type 2 diabetes develops when the body’s cells become resistant to the hormone insulin and the pancreas can no longer produce enough insulin to overcome that resistance.

Unlike sudden acute illnesses, Type 2 diabetes typically progresses gradually over many years. Because mild or moderately elevated blood glucose often causes no noticeable physical discomfort early on, many individuals live with the condition without realising it until routine blood screening or the emergence of complications—prompts a diagnosis. Early detection and consistent, individualised management substantially reduce the risk of long-term damage to the heart, blood vessels, kidneys, nerves, and eyes. This guide explains how Type 2 diabetes develops, its underlying causes and risk factors, diagnostic criteria, modern treatment strategies, remission potential, and long-term health protection.

What Is Type 2 Diabetes?

What Happens to Blood Glucose?

Under normal physiological conditions, carbohydrates consumed in food are broken down during digestion into glucose, a simple sugar absorbed into the bloodstream to fuel cells throughout the body. As blood glucose rises after a meal, specialised beta cells in the pancreas release the hormone insulin into the bloodstream. Insulin acts like a key unlocking receptors on muscle, fat, and liver cells, allowing glucose to move out of the blood and inside cells for energy or storage, keeping blood glucose within a narrow, healthy range.

In Type 2 diabetes, this signalling pathway breaks down. Glucose remains elevated in the bloodstream rather than entering cells efficiently, depriving tissues of fuel while exposing blood vessels to chronic high sugar levels.

What Is Insulin Resistance?

Insulin resistance occurs when cells in insulin-sensitive tissues respond poorly to normal levels of insulin:

  • Skeletal Muscle: Muscle cells absorb less glucose from the bloodstream after meals.
  • Liver: Normally, insulin signals the liver to stop releasing stored glucose after eating. With hepatic insulin resistance, the liver continues producing and releasing glucose inappropriately, contributing to elevated fasting blood sugar.
  • Adipose (Fat) Tissue: Excess or dysfunctional adipose tissue releases free fatty acids and inflammatory signalling molecules (adipokines) that further impair insulin signalling across muscle and liver cells.

What Happens When Insulin Production Becomes Insufficient?

Initially, the pancreas compensates for insulin resistance by working harder and secreting higher amounts of insulin (hyperinsulinaemia), temporarily keeping blood glucose near normal. Over time, however, sustained metabolic stress leads to progressive pancreatic beta-cell dysfunction—meaning beta cells gradually lose their ability to secrete sufficient insulin in response to glucose spikes. Importantly, Type 2 diabetes is not simply a condition where “the body stops producing insulin”; rather, it reflects a dual defect of insulin resistance paired with progressive beta-cell dysfunction relative to the body’s needs.

How Does Type 2 Diabetes Develop?

The progression from normal glucose regulation to established Type 2 diabetes unfolds as a gradual physiological sequence:

  1. Genetic Susceptibility and Environmental Factors: Inherited metabolic predispositions interact with lifestyle and environmental influences such as excess visceral fat and reduced physical activity.
  2. Insulin Resistance: Muscle, liver, and adipose tissues become progressively less responsive to circulating insulin.
  3. Compensatory Insulin Production: Pancreatic beta cells increase insulin secretion (hyperinsulinaemia) to keep blood glucose within normal limits.
  4. Progressive Beta-Cell Dysfunction: Over years of sustained demand and metabolic stress, beta cells gradually lose secretory capacity and functional mass.
  5. Insufficient Insulin Action and Persistent Hyperglycaemia: Insulin output can no longer overcome tissue resistance, causing fasting and post-meal blood glucose levels to remain chronically elevated and establishing Type 2 diabetes.

What Causes Type 2 Diabetes?

There is no single isolated cause of Type 2 diabetes. Instead, the condition arises from a complex interaction between inherited genetic predisposition, metabolic biology, ageing, and environmental or lifestyle factors:

  • Genetic Susceptibility: Inherited variations in genes influencing beta-cell function, insulin signalling, and fat distribution explain why Type 2 diabetes frequently runs in families and occurs at higher rates in certain ethnic populations.
  • Insulin Resistance: Core metabolic resistance across muscle, liver, and fat tissues.
  • Excess Body Fat and Visceral Fat: Fat stored deep around abdominal organs (visceral adiposity) and ectopic fat accumulating inside the liver and pancreas are strongly linked to insulin resistance and beta-cell stress.
  • Physical Inactivity: Regular muscle contraction stimulates glucose uptake independently of insulin; sedentary habits reduce muscle glucose transporter activity and worsen insulin resistance.
  • Dietary and Metabolic Factors: Energy-dense diets high in refined carbohydrates, sugary drinks, and saturated fats—combined with low dietary fibre—promote weight gain and metabolic strain.
  • Age-Related Risk: Natural declines in muscle mass, physical activity, and beta-cell reserve increase susceptibility with advancing age.
  • Other Medical Conditions: Conditions closely tied to insulin resistance—including hypertension (high blood pressure), dyslipidaemia (abnormal cholesterol/triglycerides), prediabetes, polycystic ovary syndrome (PCOS), and a history of gestational diabetes during pregnancy—substantially elevate risk.

Risk Factors for Type 2 Diabetes

Risk Factor Why It Matters
Family History Having a parent or sibling with Type 2 diabetes significantly increases genetic susceptibility
Overweight or Obesity Excess body fat is strongly associated with systemic insulin resistance
Abdominal (Visceral) Fat Fat around the waist and internal organs drives metabolic inflammation and liver fat accumulation
Physical Inactivity Reduces muscle insulin sensitivity and lowers daily glucose utilisation
Increasing Age Risk rises steadily after age 45 (and earlier in higher-risk populations)
Prediabetes Blood glucose levels above normal but below diabetes thresholds strongly predict progression
Previous Gestational Diabetes Women who had diabetes during pregnancy face a substantially higher lifetime risk of Type 2 diabetes
Polycystic Ovary Syndrome (PCOS) Closely linked with underlying insulin resistance and metabolic dysfunction
Hypertension Frequently coexists with insulin resistance as part of cardiometabolic syndrome
Dyslipidaemia Low HDL cholesterol and high triglycerides reflect underlying insulin resistance

Important Clarification: While excess weight is a major risk factor, Type 2 diabetes can and does occur in people who are not overweight or obese. Genetic factors, visceral liver fat (“thin on the outside, fat on the inside”), age, and reduced beta-cell capacity can drive Type 2 diabetes even at a normal body mass index (BMI).

What Are the Symptoms of Type 2 Diabetes?

Common Symptoms

When blood glucose rises significantly, classic symptoms may include:

  • Increased thirst (polydipsia) as the body tries to replace lost fluids.
  • Frequent urination (polyuria), especially waking at night, as kidneys filter excess glucose into urine.
  • Increased hunger (polyphagia) because cells are unable to access circulating glucose for fuel.
  • Persistent fatigue and lethargy.
  • Blurred vision, caused by temporary fluid shifts changing the shape of the eye’s lens.
  • Slow-healing cuts, grazes, or sores.
  • Recurrent infections, such as skin infections, urinary tract infections, or thrush.
  • Tingling, numbness, or burning sensations in the hands or feet.
  • Unexplained weight loss, occurring when insufficient insulin action forces the body to break down muscle and fat stores.

Why Can Type 2 Diabetes Go Unnoticed?

Because blood glucose often climbs slowly over years, the body adapts to mildly elevated sugar levels without triggering dramatic warning signs. Many people feel entirely well at the time of diagnosis—which is why proactive blood screening in adults with risk factors is essential.

When Should Someone See a Doctor?

Anyone experiencing classic symptoms—or adults with risk factors such as family history, excess waist circumference, high blood pressure, PCOS, or previous gestational diabetes—should consult a doctor for a formal blood glucose assessment rather than attempting to self-diagnose.

Prediabetes and Type 2 Diabetes – What’s the Difference?

What Is Prediabetes?

Prediabetes (encompassing impaired fasting glucose and impaired glucose tolerance) is an intermediate metabolic state in which blood glucose levels are higher than normal, but not yet high enough to meet the diagnostic threshold for Type 2 diabetes.

How Is Prediabetes Different From Diabetes?

In prediabetes, insulin resistance is already present, yet the pancreas still produces enough insulin to prevent overt diabetic hyperglycaemia. While prediabetes rarely causes symptoms, it signals heightened risk for both developing Type 2 diabetes and experiencing cardiovascular disease.

Can Prediabetes Progress to Type 2 Diabetes?

Without intervention, many individuals with prediabetes eventually develop Type 2 diabetes over subsequent years. However, progression is not inevitable.

Can Type 2 Diabetes Be Prevented or Delayed?

Landmark clinical trials worldwide—including the Diabetes Prevention Program (DPP)—demonstrate that structured lifestyle modifications (modest weight loss of 5–7% of body weight, regular moderate-intensity physical activity, and improved dietary quality) can reduce or delay progression from prediabetes to Type 2 diabetes by over 50%.

Diagnostic Tests Explained

  • HbA1c: Measures the percentage of haemoglobin proteins in red blood cells coated with glucose, reflecting average blood glucose levels over the preceding 8 to 12 weeks without requiring fasting.
  • Fasting Plasma Glucose (FPG): Measures blood glucose after at least 8 hours of overnight fasting (water only).
  • Oral Glucose Tolerance Test (OGTT): Measures fasting glucose, followed by drinking a standardised 75-gram glucose solution and re-testing blood glucose exactly 2 hours later to assess how efficiently the body clears a glucose load.
  • Random Plasma Glucose: A blood sample taken at any time of day regardless of recent meals; a result of confirms diabetes immediately if the person also has classic symptoms of hyperglycaemia or hyperglycaemic crisis.
  • Why May Testing Need to Be Repeated? In the absence of unequivocal hyperglycaemic symptoms, doctors repeat the diagnostic test (or confirm with a second distinct test) on a subsequent day to rule out laboratory error or temporary stress-induced glucose spikes.

What Is HbA1c and Why Is It Important?

  • What Does HbA1c Measure? Because red blood cells circulate for roughly 120 days, glycated haemoglobin (HbA1c) provides a reliable long-term picture of average blood glucose exposure rather than a single snapshot.
  • What Does an HbA1c Result Mean? Higher HbA1c percentages correlate directly with greater long-term risk of microvascular and macrovascular complications. For most non-pregnant adults with Type 2 diabetes, guidelines commonly aim for an HbA1c target around (53 mmol/mol), though doctors individualise targets (for example, aiming slightly higher in frail older adults to avoid low blood sugar).
  • How Often Is HbA1c Monitored? Typically checked every 3 months when treatment is changing or blood glucose targets are not yet met, and every 6 months once glycaemic control is stable.
  • Conditions That Affect HbA1c Accuracy: Any condition that alters red blood cell lifespan or haemoglobin structure—such as iron-deficiency anaemia, haemolytic anaemia, recent blood transfusion, chronic kidney disease, pregnancy, or haemoglobin variants (such as sickle cell trait or thalassaemia)—can skew HbA1c results, requiring doctors to rely on plasma glucose measurements or alternative markers like fructosamine.

How Is Type 2 Diabetes Treated?

There is no single treatment that is appropriate for everyone with Type 2 diabetes. Modern care is highly individualised, balancing blood glucose and HbA1c targets against a person’s cardiovascular history, kidney function, body weight, risk of low blood sugar (hypoglycaemia), age, concurrent medicines, personal preferences, treatment cost/access, and overall life goals.

Lifestyle Management for Type 2 Diabetes

Lifestyle foundations underpin every stage of Type 2 diabetes care, working alongside medications when prescribed:

  • Healthy Eating: Rather than a single rigid “diabetes diet,” accredited practising dietitians focus on overall nutritional quality, appropriate energy intake, high-fibre whole foods (vegetables, legumes, whole grains, nuts, seeds), minimally processed foods, and spreading consistent, high-quality carbohydrates evenly across meals.
  • Physical Activity: Combining regular aerobic activity (such as brisk walking, cycling, or swimming for at least 150 minutes per week) with resistance strength training two to three times weekly boosts muscle insulin sensitivity for up to 24–48 hours after each session.
  • Weight Management: For individuals carrying excess weight, sustainable weight reduction reduces liver and pancreatic fat, improves insulin sensitivity, and lowers blood pressure and lipids.
  • Sleep and Behavioural Health: Prioritising 7–8 hours of quality sleep, screening for obstructive sleep apnoea, managing chronic stress, and accessing diabetes self-management education support sustainable daily habits.

Medicines Used to Treat Type 2 Diabetes

When lifestyle measures alone do not achieve individualised glycaemic or organ-protection goals, doctors select from several evidence-based medication classes:

Metformin

  • Mechanism: Reduces excessive glucose production by the liver and improves peripheral insulin sensitivity without stimulating insulin secretion.
  • Common Role & Benefits: Widely used as an initial oral therapy due to strong glucose-lowering efficacy, low risk of hypoglycaemia when used alone, weight neutrality, and established safety profile.
  • Adverse Effects & Precautions: Temporary gastrointestinal symptoms (nausea, loose stools, abdominal bloating) are common initially and often minimised by starting at a low dose, taking tablets with meals, or using extended-release formulations. Long-term use can lower vitamin B12 levels, and dose adjustment or avoidance is required in severe kidney impairment due to rare lactic acidosis risk.

SGLT2 Inhibitors (e.g., Empagliflozin, Dapagliflozin)

  • Mechanism: Block sodium-glucose cotransporter 2 (SGLT2) proteins in the kidneys, causing excess glucose to be excreted in the urine.
  • Benefits: Lower blood glucose independently of insulin, promote modest weight and blood-pressure reductions, and provide proven cardiovascular and kidney-protective benefits (reducing heart failure hospitalisations and slowing chronic kidney disease progression) in high-risk patients.
  • Adverse Effects & Precautions: Increase the risk of genital fungal infections (thrush) and urinary tract infections, mild volume depletion, and rare euglycaemic diabetic ketoacidosis (DKA)—requiring temporary “sick-day” cessation during acute illness, fasting, or surgery.

GLP-1 Receptor Agonists (e.g., Semaglutide, Dulaglutide, Liraglutide)

  • Mechanism: Mimic the natural gut incretin hormone glucagon-like peptide-1 (GLP-1), stimulating insulin release in a glucose-dependent manner, suppressing inappropriate glucagon secretion, slowing stomach emptying, and acting on brain appetite centres.
  • Benefits: Strong HbA1c reduction, meaningful weight loss, low hypoglycaemia risk, and proven reduction in major adverse cardiovascular events for specific agents in people with established cardiovascular disease.
  • Adverse Effects: Nausea, vomiting, reflux, diarrhoea, or constipation (especially during dose escalation); caution is required in people with a history of pancreatitis or specific thyroid conditions.

Dual GIP/GLP-1 Receptor Agonists (e.g., Tirzepatide)

  • Mechanism: Activate both glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptors simultaneously.
  • Role: Offer substantial HbA1c reductions and pronounced weight-loss effects alongside low intrinsic hypoglycaemia risk, with gastrointestinal side effects similar to GLP-1 receptor agonists.

DPP-4 Inhibitors (e.g., Sitagliptin, Linagliptin, Vildagliptin)

  • Mechanism: Inhibit the dipeptidyl peptidase-4 (DPP-4) enzyme that breaks down endogenous incretin hormones, modestly enhancing glucose-dependent insulin release.
  • Role: Generally well tolerated, weight-neutral oral tablets with very low hypoglycaemia risk, offering moderate glucose lowering.

Sulfonylureas (e.g., Gliclazide, Glimepiride)

  • Mechanism: Directly stimulate pancreatic beta cells to secrete more insulin regardless of current blood glucose levels.
  • Precautions: Effective and inexpensive glucose-lowering agents, but carry a notable risk of hypoglycaemia (low blood sugar) and modest weight gain, requiring careful dosing and glucose monitoring.

Thiazolidinediones (e.g., Pioglitazone)

  • Mechanism: Activate PPAR-gamma nuclear receptors to increase insulin sensitivity in fat, muscle, and liver tissues.
  • Safety Considerations: Effective insulin sensitisers, but associated with fluid retention, weight gain, increased fracture risk, and contraindication in heart failure.

Insulin

  • When Required: Because beta-cell function can decline over time, many people with Type 2 diabetes eventually benefit from basal (long-acting) or mealtime insulineither temporarily during acute illness or long-term to achieve safe blood glucose control. Insulin requires education on injection technique, blood glucose monitoring, and hypoglycaemia prevention.

How Doctors Choose a Type 2 Diabetes Medicine

Contemporary international and Australian guidelines move away from a rigid one-size-fits-all sequence, instead using a structured, risk-stratified clinical decision process:

  1. Assess Cardiovascular Disease or High Cardiovascular Risk: If established atherosclerotic cardiovascular disease or heart failure is present, clinicians prioritise a GLP-1 receptor agonist or an SGLT2 inhibitor with proven cardiovascular benefit, independent of baseline HbA1c.
  2. Assess Chronic Kidney Disease or Albuminuria: If reduced kidney function or urinary protein leakage is present, an SGLT2 inhibitor (or a dedicated kidney-protective GLP-1 receptor agonist) is prioritised to slow kidney disease progression.
  3. Assess Weight Management Needs: Where weight reduction is a primary therapeutic goal, doctors favour glucose-lowering therapies that support weight loss (such as GLP-1 or dual GIP/GLP-1 receptor agonists) or weight neutrality (such as SGLT2 inhibitors, metformin, or DPP-4 inhibitors).
  4. Assess Hypoglycaemia Vulnerability: For older adults, people living alone, or individuals in safety-critical occupations, clinicians avoid or minimise medicines that cause low blood sugar (such as sulfonylureas or insulin) whenever safer alternatives are appropriate.
  5. Assess Current HbA1c, Comorbidities, and Access: Finally, the doctor evaluates how much glucose reduction is needed, checks concurrent medicines and organ function, considers cost and Pharmaceutical Benefits Scheme (PBS) eligibility, and agrees on an individualised treatment plan with the patient.

Type 2 Diabetes and Cardiovascular Disease

Cardiovascular disease including coronary artery disease, heart attack (myocardial infarction), stroke, heart failure, and peripheral arterial disease—is the leading cause of serious morbidity and mortality in people with Type 2 diabetes. Chronic hyperglycaemia and insulin resistance accelerate endothelial dysfunction, arterial inflammation, and plaque buildup (atherosclerosis).

Why Blood Glucose Isn’t the Only Concern

Protecting heart and blood vessel health requires comprehensive multifactorial risk reduction:

  • Controlling blood pressure (often aiming below 130/80 mmHg where tolerated).
  • Managing blood lipids (frequently using statin therapy to lower LDL cholesterol).
  • Complete smoking cessation.
  • Maintaining healthy body weight and regular physical activity.
  • Monitoring and protecting kidney function, alongside steady glycaemic control.

Type 2 Diabetes and Kidney Disease

  • How Diabetes Damages the Kidneys: Persistent high blood glucose and elevated pressure inside the kidneys’ microscopic filtering units (glomeruli) gradually scar and thicken filtering membranes—a condition termed diabetic kidney disease (diabetic nephropathy).
  • Albuminuria and Kidney Function: Early kidney damage allows tiny amounts of protein (albuminuria, measured via a urine albumin-to-creatinine ratio, uACR) to leak into urine before overall filtering speed (eGFR) declines.
  • Why Regular Kidney Monitoring Matters: Annual urine uACR and blood eGFR tests detect early, silent kidney strain when interventions are most effective.
  • How Modern Diabetes Medicines Affect Kidney Outcomes: Alongside ACE inhibitors or angiotensin receptor blockers (ARBs), clinical trials show that SGLT2 inhibitors (and certain GLP-1 receptor agonists in dedicated kidney outcome trials) significantly slow kidney function decline and reduce kidney failure risk in people with Type 2 diabetes and chronic kidney disease.

Type 2 Diabetes and Nerve Damage

  • Peripheral Neuropathy: Prolonged elevated blood glucose damages delicate peripheral nerve fibres and the tiny blood vessels supplying them, most commonly affecting the longest nerves running to the feet and lower legs. Symptoms include tingling (“pins and needles”), burning pain, shooting pains, numbness, or loss of temperature and touch sensation.
  • Why Foot Care Matters: When protective sensation in the feet is dulled, a person may not feel a tight shoe rubbing, a small pebble, a blister, or a minor burn. Combined with reduced circulation, unnoticed foot injuries can rapidly develop into slow-healing foot ulcers and serious infections—making daily foot inspection, well-fitting footwear, and annual podiatry/foot checks essential.

Type 2 Diabetes and Eye Disease

  • Diabetic Retinopathy: High blood glucose weakens and damages tiny blood vessels in the light-sensitive retina at the back of the eye, causing microaneurysms, fluid leakage, or fragile abnormal new blood vessels that can bleed and threaten sight.
  • Diabetic Macular Oedema: Fluid accumulation in the central macula—the part of the retina responsible for sharp straight-ahead reading and facial recognition—can blur central vision.
  • Why Regular Eye Examinations Matter: Early diabetic retinopathy rarely causes noticeable vision changes. Comprehensive dilated retinal examinations every 1 to 2 years (or more often if changes are detected) allow early laser or intravitreal treatments that prevent over 90% of severe vision loss.

Other Long-Term Complications of Type 2 Diabetes

With consistent management of blood glucose, blood pressure, and cholesterol, many people live long, active lives without severe complications. However, poorly controlled diabetes over time increases the risk of:

  • Cardiovascular events (heart attack, stroke, heart failure)
  • Chronic kidney disease
  • Peripheral and autonomic neuropathy (which can also affect digestion, heart rate, and bladder or sexual function)
  • Diabetic retinopathy and cataracts
  • Foot ulcers and lower-limb amputations
  • Peripheral arterial disease (poor leg circulation)
  • Increased susceptibility to bacterial and fungal infections
  • Dental and periodontal (gum) disease, which in turn can make blood glucose harder to control

Can Type 2 Diabetes Be Reversed?

Diabetes Remission vs Cure

Clinicians prefer the term diabetes remission rather than “cure.” Remission is defined internationally as maintaining an HbA1c below () for at least 3 months without taking any glucose-lowering medications. Because underlying genetic susceptibility and metabolic sensitivity remain, blood glucose can rise again if weight is regained or habits shift.

Can Weight Loss Lead to Remission?

Yes, in selected individuals—particularly within the first 6 years of diagnosis. Clinical trials (such as the UK DiRECT trial) demonstrated that substantial, structured weight loss often 10–15 kg or more—reduces excess fat inside the liver and pancreas, restoring hepatic insulin sensitivity and allowing recovering beta cells to resume normal insulin secretion in a significant proportion of participants.

Role of Metabolic/Bariatric Surgery

For adults with Type 2 diabetes and severe obesity who have not achieved remission or glycaemic targets through lifestyle and medical therapy, metabolic (bariatric) surgery produces high rates of durable diabetes remission alongside reduced cardiovascular risk.

Why Remission Requires Continued Monitoring

Even when blood glucose returns to the normal range off medication, individuals in remission must continue regular HbA1c, blood pressure, lipid, eye, and kidney checks to ensure early detection if hyperglycaemia returns.

Can Type 2 Diabetes Be Prevented?

  • Identifying High-Risk People: Using validated risk-assessment tools (such as the Australian Type 2 Diabetes Risk Assessment Tool, AUSDRISK) and screening blood tests helps identify individuals with prediabetes early.
  • Weight Management: Losing 5–7% of body weight substantially reduces diabetes incidence.
  • Physical Activity: Aiming for at least 30 minutes of moderate physical activity on most days improves insulin sensitivity.
  • Dietary Improvement: Prioritising whole grains, vegetables, legumes, lean proteins, and water over sugary drinks and ultra-processed foods.
  • Prediabetes Monitoring: Annual blood glucose and HbA1c reviews track progress and allow timely intervention.

Type 2 Diabetes in Different Age Groups

  • Younger Adults (Under 40): Early-onset Type 2 diabetes often involves more aggressive beta-cell decline and longer lifetime exposure to elevated glucose, making early, proactive glycaemic and cardiovascular risk management particularly important.
  • Middle-Aged Adults: Balancing career and family demands with structured physical activity, weight management, and regular cardiometabolic screening helps prevent midlife vascular complications.
  • Older Adults (Over 65–70): While active, healthy older adults benefit from standard glycaemic targets, frail older adults with multiple medical conditions often require relaxed HbA1c targets (e.g., ) and careful medication selection to avoid dangerous episodes of low blood sugar (hypoglycaemia), dizziness, and falls.

Type 2 Diabetes in Australia

According to the Australian Institute of Health and Welfare (AIHW) and Diabetes Australia, over 1.3 million Australians are living with diagnosed diabetes—with Type 2 diabetes accounting for roughly 85% to 90% of all cases—while hundreds of thousands more are estimated to be living with undiagnosed diabetes or prediabetes.

  • Australian Risk Context: Higher prevalence is observed among older Australians, people living in regional and remote areas, lower socioeconomic groups, and Aboriginal and Torres Strait Islander peoples, who experience disproportionately earlier onset and higher complication rates.
  • Care and Access in Australia: Australian general practitioners (GPs) coordinate care alongside credentialled diabetes educators, accredited practising dietitians, podiatrists, and optometrists through GP Chronic Condition Management Plans. Subsidised glucose monitoring supplies and support programs are available via the National Diabetes Services Scheme (NDSS), while registered diabetes medicines are evaluated for safety, quality, and efficacy by the Therapeutic Goods Administration (TGA) and supplied via valid Australian prescriptions.

Type 2 Diabetes Worldwide

According to the International Diabetes Federation (IDF) Diabetes Atlas (11th Edition, 2025):

  • Global Prevalence: Approximately 589 million adults aged 20–79 worldwide were living with diabetes in 2025 (roughly 1 in 9 adults globally), with over 90% having Type 2 diabetes—and more than 4 in 10 remaining undiagnosed.
  • Why Diabetes Is Increasing: Rapid urbanisation, ageing populations, increasingly sedentary occupations, and shifts toward energy-dense processed diets are driving rising global rates.
  • Regional Differences & Low- and Middle-Income Countries: Over 80% of adults with diabetes live in low- and middle-income countries, with the Western Pacific, South-East Asia, and Middle East/North Africa regions carrying the highest numbers and prevalence rates.
  • Future Projections: Without coordinated public health prevention, the IDF projects global adult diabetes cases will rise to roughly 853 million by 2050.

Type 2 Diabetes vs Type 1 Diabetes

Feature Type 1 Diabetes Type 2 Diabetes
Main Mechanism Autoimmune destruction of insulin-producing pancreatic beta cells Insulin resistance combined with progressive beta-cell dysfunction
Insulin Production Eventually very low or completely absent Often normal or elevated initially, declining gradually over time
Typical Onset Most commonly diagnosed in children, adolescents, or young adults—but can occur at any age Most common in adults over 45, though increasingly diagnosed in younger adults
Symptom Onset Usually rapid (over days to weeks) Usually gradual (over months to years); often asymptomatic early on
Insulin Required? Yes—lifelong insulin therapy is essential from diagnosis Sometimes—managed with lifestyle, oral/injectable medicines, and insulin if needed
Prevention Currently not routinely preventable Often preventable or delayable in high-risk individuals through lifestyle changes

Authoritative Australian & International References

  1. Australian Institute of Health and Welfare (AIHW). Diabetes: Australian Facts. Canberra: AIHW; 2025/2026. Available at:

  2. Diabetes Australia & Royal Australian College of General Practitioners (RACGP). Management of Type 2 Diabetes: A Handbook for General Practice.

  3. Healthdirect Australia. Type 2 Diabetes – Symptoms, Causes, Diagnosis and Management. Australian Government Department of Health and Aged Care.

  4. International Diabetes Federation (IDF). IDF Diabetes Atlas, 11th Edition (2025). Brussels: IDF; 2025.

  5. American Diabetes Association (ADA). Standards of Care in Diabetes—2026. Diabetes Care.

Medical Disclaimer: This article is intended for educational and informational purposes only and does not constitute personalised medical advice, diagnosis, or treatment. Always consult an Australian-registered general practitioner, endocrinologist, credentialled diabetes educator, or pharmacist regarding diabetes screening, blood glucose targets, or prescribed medications. In a medical emergency, call Triple Zero (000) immediately.

FAQ

What is Type 2 diabetes?

Type 2 diabetes is a chronic metabolic condition in which blood glucose levels remain elevated because the body's cells respond poorly to insulin (insulin resistance) and the pancreas gradually cannot produce enough insulin to maintain normal blood sugar levels.

What are the first symptoms of Type 2 diabetes?

Early signs can include increased thirst, frequent urination, unusual fatigue, blurred vision, slow-healing cuts, and recurring minor infections. However, many people have no noticeable symptoms at all in the early stages.

Can Type 2 diabetes be cured?

There is currently no permanent cure for Type 2 diabetes, because underlying genetic and metabolic susceptibilities remain. However, significant weight loss and lifestyle changes—particularly soon after diagnosis—can place Type 2 diabetes into remission, maintaining normal blood glucose without medication.

What causes Type 2 diabetes?

Type 2 diabetes is caused by a combination of genetic predisposition and environmental or metabolic factors most notably insulin resistance, excess abdominal and liver fat, physical inactivity, advancing age, and conditions like prediabetes or previous gestational diabetes.v

Can a person have Type 2 diabetes without symptoms?

Yes. Because blood glucose typically rises gradually over many years, Type 2 diabetes frequently causes no obvious symptoms at first. Many people are diagnosed during routine blood tests before any symptoms appear.

Is Type 2 diabetes reversible?

While not permanently cured, Type 2 diabetes can often be put into remission meaning blood glucose returns to non-diabetic levels off medicationthrough substantial, sustained weight loss, healthy nutrition, regular physical activity, or metabolic surgery in eligible individuals.

What medicines are used for Type 2 diabetes?

Common medication classes include metformin, SGLT2 inhibitors, GLP-1 receptor agonists, dual GIP/GLP-1 receptor agonists, DPP-4 inhibitors, sulfonylureas, thiazolidinediones, and insulin. Doctors select medicines based on individual HbA1c, heart health, kidney function, weight, and safety factors.

Can Type 2 diabetes cause kidney problems?

Yes. Persistently high blood glucose and high blood pressure can gradually damage the kidneys' delicate filtering units, leading to diabetic kidney disease. Annual urine protein and blood kidney function tests help detect and treat early kidney changes.

Can Type 2 diabetes be prevented?

In many high-risk individuals—especially those with prediabetes—Type 2 diabetes can be prevented or significantly delayed by achieving modest weight loss (5–7%), engaging in regular physical activity, eating a balanced high-fibre diet, and avoiding tobacco.

Dr. Arjun Srivastav (Medical Reviewer (Pharm D))

Clinical Pharmacist (Pharm D) Doctor of Medicine (MD) – University of Melbourne Biomedical Engineering – Monash University Graduate Diploma in Clinical Practice - University of Sydney, Arjun Srivastav is a…

Read full bio